TickerFacts.

Tenax Therapeutics, Inc. (TENX): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the years ended 2012-04-30, 2020-12-31, 2021-12-31, 2022-12-31, 2023-12-31 (for example after a spin-off or a discontinued operation), while the year before each was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

-$19.49M
Year ended 2024-12-31
$11.06M2011-04-30: $10.87M2012-04-30: -$8.01M2013-04-30: -$5.04M2014-04-30: -$16.46M2015-04-30: -$14.67M2016-12-31: -$52.63M2017-12-31: -$9.19M2018-12-31: -$6.88M2019-12-31: -$8.55M2020-12-31: $9.87M2021-12-31: -$32.72M2022-12-31: $11.06M2023-12-31: -$8.23M2024-12-31: -$19.49M-$19.49M
2011-04-30 EBITDA (USD) 2024-12-31
Period endedEBITDAChange YoYSource filing
2024-12-31-$19.49Mn/m2026-03-10, From 2024-01-01
2023-12-31-$8.23Mn/c2025-03-25, From 2023-01-01
2022-12-31$11.06Mn/c2024-03-28, From 2022-01-01
2021-12-31-$32.72Mn/c2023-03-31, From 2021-01-01
2020-12-31$9.87Mn/c2022-03-29, From 2020-01-01
2019-12-31-$8.55Mn/m2021-04-16, From 2019-01-01
2018-12-31-$6.88Mn/m2020-03-30, From 2018-01-01
2017-12-31-$9.19Mn/m2019-04-01, From 2017-01-01
2016-12-31-$52.63Mn/a2018-04-02, From 2016-01-01
No annual figure between 2015-04-30 and 2016-12-31.
2015-04-30-$14.67Mn/m2017-03-16, From 2014-05-01
2014-04-30-$16.46Mn/m2017-03-16, From 2013-05-01
2013-04-30-$5.04Mn/m2014-07-29, From 2012-05-01
2012-04-30-$8.01Mn/c2013-06-26, From 2011-05-01
2011-04-30$10.87Mn/a2012-07-25, From 2010-05-01